F S&P 500
5,321.00 +0.75 (+0.01%) F Dow Jones
40,010.00 0.00 (0.00%) F Nasdaq
18,658.75 +8.75 (+0.05%) E-mini Russell 2000 Index Futur
2,104.20 -0.70 (-0.03%) Petróleo
79.43 +0.20 (+0.25%) Oro
2,381.20 -4.30 (-0.18%)
Australian Clinical Labs Limited (ACL.AX)
Australian Clinical Labs Limited
1868-1892 Dandenong Road
Clayton, VIC 3168
Australia
61 1 3004 53688
https://www.clinicallabs.com.au
Sector(es): Healthcare
Industria: Diagnostics & Research
Empleados a tiempo completo: 5,115
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Ms. Melinda McGrath | CEO & Executive Director | 1.01M | N/D | N/D |
| Mr. James Davison | Chief Financial Officer | 540.69k | N/D | N/D |
| Mr. Anthony Friedli | Chief Operating Officer | N/D | N/D | N/D |
| Mr. Sean Jackson | Chief Information Officer | N/D | N/D | N/D |
| Mr. Joe Geran | National Marketing Director | N/D | N/D | N/D |
| Associate Prof. Tony Landgren | National Medical Director & Chief Pathologist | N/D | N/D | N/D |
| Mr. Chris Brownlow | Chief Executive Officer of New South Wales & Australian Capital Territory | N/D | N/D | N/D |
| Ms. Shae Seymour | Chief Executive Officer of Western Australia | N/D | N/D | N/D |
| Mr. Eric Swayn | Chief Executive Officer of South Australia & Northern Territory | N/D | N/D | N/D |
| Ms. Eleanor Padman B.A., FCIS | Company Secretary | N/D | N/D | N/D |
Descripción
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.
Gestión corporativa
La calificación ISS Governance QuickScore de Australian Clinical Labs Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
